What Is New With Acne During Pregnancy in September 2026? Latest FDA and dermatology sources and Key Takeaways

In September 2026, the biggest acne-related change in pregnancy care is an upcoming iPLEDGE update for isotretinoin, while dermatology guidance continues to favor selected topical ingredients. iPLEDGE is the FDA safety program for isotretinoin, a powerful oral acne medicine with pregnancy risks. The FDA delayed implementation of approved iPLEDGE modifications from August 8 to November 15, 2026. For pregnancy acne itself, benzoyl peroxide, azelaic acid, and carefully selected acids remain the main options discussed by dermatology and teratology sources.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Official resources:

Read the official guidance from FDA — Use this primary source to verify the official guidance.
Explore the official data from FDA — Use this primary source to review the underlying data.

What is changing in iPLEDGE?
Which acne ingredients are considered reasonable during pregnancy?
What should be avoided or reviewed carefully?
How do general acne guidelines fit pregnancy care?
Frequently Asked Questions

What is changing in iPLEDGE?

The FDA approved iPLEDGE modifications on February 9, 2026. The changes affect patients who can become pregnant, isotretinoin prescribers, and pharmacies, but implementation is now scheduled for November 15, 2026, according to the FDA's June 16, 2026 update.

Under the approved changes, eligible patients may use prescriber-approved at-home pregnancy tests during and after isotretinoin treatment. The pretreatment pregnancy test must still take place in a medical setting, so at-home testing does not replace every required clinical step. Until the implementation date, patients and prescribers should follow the iPLEDGE procedures currently in effect for their treatment.

Which acne ingredients are considered reasonable during pregnancy?

MotherToBaby's February 2026 review reports that ACOG supports pregnancy-needed over-the-counter products containing benzoyl peroxide, azelaic acid, salicylic acid, or glycolic acid. Patients should read the full label because a product may contain additional active ingredients; the MotherToBaby pregnancy-acne review specifically advises checking for them. The American Academy of Dermatology describes azelaic acid as thought to be safe during pregnancy.

It also considers benzoyl peroxide and limited-duration salicylic acid generally acceptable, while emphasizing that treatment evidence remains incomplete and clinician review is appropriate. Topical products generally create much lower fetal exposure than oral acne medicines. When used as directed, MotherToBaby reports no association with increased risks of birth defects, miscarriage, preterm delivery, or low birth weight.

What should be avoided or reviewed carefully?

Topical retinoids, including tretinoin and adapalene, remain products to avoid during pregnancy. MotherToBaby notes that absorption through skin is low, but evidence in pregnancy is limited, and oral retinoids are established causes of birth defects.

Do not assume that every acne product is safe because it is labeled "topical." Check the active-ingredient list for retinoids and other added ingredients before use, especially in combination products. Winlevi, or clascoterone, is not an established pregnancy-safe acne option. The FDA-posted label contains no human pregnancy data and describes malformations in rats and pregnancy loss or resorptions in rabbits at specified animal exposures; the FDA Winlevi label also warns that the posted label may not be the latest version.

How do general acne guidelines fit pregnancy care?

The AAD's January 2024 acne-guideline update conditionally recommends clascoterone, salicylic acid, azelaic acid, and hormonal therapies for acne generally. Those recommendations address acne treatment across the population, not automatic approval for use during pregnancy.

Pregnancy changes the decision because fetal exposure, limited safety evidence, and the severity of acne all matter. The AAD also reported insufficient evidence for several procedures, including laser and light devices, so pregnancy treatment involving procedures requires individualized obstetric-dermatology advice. A practical review with a clinician should cover:.

Every active ingredient in the product.
Whether treatment is topical or oral.
Whether the product is needed for mild acne or more severe disease.
Whether an existing prescription should be stopped, changed, or continued.

Frequently Asked Questions

Can patients use at-home pregnancy tests for isotretinoin in September 2026?

The approved changes allow prescriber-approved at-home tests during and after treatment, but implementation is scheduled for November 15, 2026. The pretreatment test remains medical-setting based.

Is azelaic acid considered safe during pregnancy?

The AAD says azelaic acid is thought safe, and MotherToBaby reports that ACOG supports pregnancy-needed OTC products containing it.

Should topical tretinoin or adapalene be used during pregnancy?

MotherToBaby recommends avoiding topical retinoids during pregnancy because safety evidence remains limited.